Search

everythinglearnresearchcommunity

for

Search:↓

A new peptide from ginseng berries may help prevent hair loss by promoting cell growth and reducing stress damage.

Rutin may help regrow hair by stabilizing β-catenin and blocking GSK3β.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Oenocarpus bataua vegetable oil may help reduce hair loss by affecting a key gene pathway.

Linagliptin slows down premature aging in certain mice.

GLP-1RA therapy may increase the risk of hair loss.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.